MedPath

A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™

Not Applicable
Completed
Conditions
Fibreoptic Intubation
Airway Management
Laryngeal Mask Airway
Interventions
Device: Crossover Ambu Aura-i™ / LMA ETT™
Device: Crossover Ambu Aura-i™ / Rüsch Super Safety Silk™
Device: Crossover FASTRACH™ / Rüsch Super Safety Silk™
Device: Crossover FASTRACH™ / LMA ETT™
Registration Number
NCT03109678
Lead Sponsor
Asklepios Kliniken Hamburg GmbH
Brief Summary

The intubating laryngeal mask Fastrach™ is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask. Recently, a single use version of the mask has been introduced. The Fastrach single use laryngeal mask is beng compared to the new, low-priced single use intubating laryngeal mask Ambu Aura-i™.

Detailed Description

Eighty patients undergoing general anaesthesia with planned tracheal intubation for elective surgical procedures are enrolled in the study after checking for inclusion and exclusion criteria. Patients are randomised to either LMA group for blind tracheal intubation with either a standard PVC tracheal tube, or a specifically for the LMA Fastrach developed tube, yielding 4 subgroups.

After a standardised anaesthesia induction, blind intubation is performed in each study group. Different time intervals are documented, such as time to first adequate lung ventilation, or f.e. time for laryngeal mask placement. A crossover-design is performed after unsuccessful intubation, using the alternate LMA or the other tracheal tube. LMA placement is visualised by fibreoptic control.

An estimated success rate for blind intubation of 60% in the Aura-i group versus 90% in the Fastrach group yields a sample size of n= 38. To compensate for dropouts, n=40 subjects are enrolled in each group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • patients undergoing planned general anaesthesia
  • planned tracheal intubation
  • elective surgical procedure
  • 15 to 80 years of age
Exclusion Criteria
  • ASA physical status IV and V
  • severe pulmonary comorbidity (COPD GOLD >III, bronchial asthma)
  • indication for rapid-sequence induction
  • mouth opening (interincisor distance) <3cm
  • morbid obesity (BMI >35kg.m-2)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Aura-i / LMA ETTCrossover Ambu Aura-i™ / LMA ETT™Blind tracheal intubation: Combination of laryngeal mask Ambu Aura-i™ with LMA ETT™ tracheal tube
Aura-i / RüschCrossover Ambu Aura-i™ / Rüsch Super Safety Silk™Blind tracheal intubation: Combination of laryngeal mask Ambu Aura-i™ with Rüsch Super Safety Silk™ tracheal tube
Fastrach / RüschCrossover FASTRACH™ / Rüsch Super Safety Silk™Blind tracheal intubation: Combination of laryngeal mask Fastrach™ with Rüsch Super Safety Silk™ tracheal tube
Fastrach / LMA ETTCrossover FASTRACH™ / LMA ETT™Blind tracheal intubation: Combination of laryngeal mask Fastrach™ with LMA ETT™ tracheal tube
Primary Outcome Measures
NameTimeMethod
success rate of blind intubationthrough study completion; time frame for individual study patient: two attempts of blind tracheal intubation peri-interventional, time maximum of 300 seconds

overall success rate of blind tracheal intubation within two attempts using either the FASTRACH™ laryngeal mask or the Ambu Aura-i™ laryngeal mask

Secondary Outcome Measures
NameTimeMethod
subjective handling scorethrough study completion; the handling of the laryngeal masks during the first placement attempt within 60 seconds; directly after placing laryngeal masks and before fibreoptic visualisation, the subjective handling score is documented as above

subjective handling score for the two compared laryngeal masks, rated as excellent (1) - poor (4)

influence of tracheal tubesthrough study completion; time frame for individual study patient: two attempts of blind tracheal intubation peri-interventional, time maximum of 300 seconds

influence of success rates of blind tracheal intubation using different tracheal tubes (Rüsch or LMA-ETT)

equivalence of the laryngeal masks regarding fibreoptic visualisationthrough study completion; after placing the laryngeal mask and checking for airway leak pressure, fibreoptic visualisation is performed within 60 seconds

fibreoptic control of laryngeal mask placement (Fastrach and Aura-i); the position of the larynx relative to the laryngeal cuff and mask-aperture is visualised and categorised as "correct", "lateral deviation", "epiglottic downfolding" or "not assessable"; additionally, the view on the larynx comparable to Cormack/Lehane score is recorded

differences in airway leak pressurethrough study completion; right after placing the laryngeal mask and checking for correct positioning, ALP is documented within 60 seconds

differences in airway leak pressure (ALP) of the two compared laryngeal masks, in cm H2O; presence of audible leakage as well as the absence of corresponding pressure increase on the monitor recorded by setting the APL valve to 40cm H2O, and fresh gas flow at 3l/min

incidence of postoperative sore throat and hoarsenesspatient interview 24 hours post procedural

incidence of postoperative sore throat and hoarseness as well as difficulty swallowing as reported by the study patients ("none", "moderate", "severe")

© Copyright 2025. All Rights Reserved by MedPath